Basic information Safety Supplier Related

laninamivir octanoate

Basic information Safety Supplier Related

laninamivir octanoate Basic information

Product Name:
laninamivir octanoate
Synonyms:
  • (4S,5R,6R)-5-Acetamido-4-guanidino-6-[(1R,2R)-2-hydroxy-1-methoxy-3-(octanoyloxy)propyl]-5,6-dihydro-4H-pyran-2-carboxylic acid
  • CS 8958
  • D-Glycero-D-galacto-non-2-enonic acid 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-7-O-methyl-9-octanoate
  • laninamivir octanoate
  • Laninamivir Octanoate Hydrate
  • (2R,3R,4S)-3-Acetamido-4-guanidino-2-[(1R,2R)-2-hydroxy-1-methoxy-3-(octanoyloxy)propyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
  • laninamivir octanoate USP/EP/BP
  • H2N2,CS8958,H3N2,inhaled,CS 8958,Laninamivir octanoate,neuraminidase,inhibit,Anti-influenza,Influenza Virus,Inhibitor
CAS:
203120-46-1
MF:
C21H36N4O8
MW:
472.53
Product Categories:
  • Amines
  • Anti-virals
  • Carbohydrates & Derivatives
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Amines, Anti-virals, Carbohydrates & Derivatives, Pharmaceuticals, Intermediates & Fine Chemicals
Mol File:
203120-46-1.mol
More
Less

laninamivir octanoate Chemical Properties

Melting point:
224-228°C (dec.)
Density 
1.35
storage temp. 
Hygroscopic, -20°C Freezer, Under Inert Atmosphere
solubility 
DMSO (Slightly), Methanol (Very Slightly)
pka
3.80±0.70(Predicted)
form 
Solid
color 
White to Off-White
Stability:
Hygroscopic
More
Less

laninamivir octanoate Usage And Synthesis

Uses

Laninamivir (L174000) prodrug; a novel long-acting neuraminidase inhibitor.

Definition

ChEBI: Laninamivir octanoate hydrate is a fatty acid ester.

Clinical Use

Laninamivir octanote, a prodrug of a potent neuraminidase inhibitor (LANI), was approved and launched in 2010 in Japan for the treatment of influenza A and influenza B. This ester prodrug of a potent neuraminidase inhibitor was designed to permeate from the lung tissue to the plasma and then hydrolyze at such a rate to reveal the active form (laninamivir) as a long-acting therapeutic agent. Neuraminidase cleaves the glycosidic linkages of neuraminic acids which are responsible for binding new viruses to infected cells, thereby allowing viruses to release and infect other cells. Neuraminidase is essential for the replication of all influenza viruses. Like other neuraminidase inhibitors, laninamivir octanoate is a sialic acid analogue which is structurally similar to zanamivir, differing only by changing one of the hydroxy groups with a methyl ether substitution on the triol side chain. Laninamivir is administered via an inhalable formulation (20 mg, dry powder inhaler) and results from clinical trials of the drug have demonstrated that a single inhaled dose is as effective as a 5-day course of oseltamivir for treatment of influenza.

Synthesis

The synthesis of laninamivir octanoate began with the well-documented sugar intermediate 101. Alcohol 101 was alkylated with dimethyl sulfate in the presence of NaH in DMF to give methyl ether 102 in 80% yield. Acetonide 102 was then deprotected and subsequently acylated with Ac2O, AcOH, and H2SO4 (10:10:1, v/v) which resulted in oxazoline formation along with elimination of the methoxy functionality to furnish |�|?-unsaturated ester 103. Exposure of oxazoline 103 to NaN3 in the presence of Dowex 50W/H+ produced the transamidoazide 104 in 70% yield over two steps. Azide 104 was then subjected to guanidine formation conditions utilizing N,N-bis(tertbutoxycarbonyl)-1H-pyrazole-1-carboxyamidine (106), which was prepared from pyrazole-1-carboxamidine (105) by consecutive protection of the amidine nitrogens, first by treatment with Boc anhydride and diisopropylethyl amine (DIEA) in DMF, and then subsequent treatment to Boc anhydride in the presence of NaH in THF to give 107 in 80% yield. The protected guanidine 107 was hydrolyzed under basic conditions to give the corresponding acid 108 in good yield. Acid 108 was esterified with diphenyl diazomethane in THF to provide 109 in 85% yield. Finally, the primary alcohol within diol 109 was selectively acylated with octanoyl chloride in the presence of TEA, followed by de-protection with TFA in CH2Cl2 to give laninamivir octanote (VIII) in 70% yield.

laninamivir octanoateSupplier

Shanghai SuperLan Chemcial Technique Centre Gold
Tel
021-2022843681 15618226720
Email
lucy@atkchemical.com
Suzhou Jianghua Biotechnology Co., Ltd Gold
Tel
0512-0000000 15151741136
Email
3045580592@qq.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Shanghai TaoSu Biochemical Technology Co., Ltd.
Tel
021-33632979
Email
info@tsbiochem.com